Today's Hours: 10:00am - 6:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Gary R. Lichtenstein, editor
    Summary: Medical Therapy of Ulcerative Colitis will serve as an invaluable resource for individual physicians use who treat patients with ulcerative colitis. The text presents a comprehensive overview of medical therapy for management of specific clinical scenarios and also a focus on the individual medications used to treat patients with ulcerative colitis. The book will be evidence based and focus on simplifying the current treatment to make it easy to understand. The chapters are written by experts in their fields and provide the most up to date information. This book will target gastroenterologists who focus on IBD, general gastroenterologists, fellows, and surgeons such as colorectal surgeons or GI surgeons who may treat patients with ulcerative colitis.

    Contents:
    The History of Medical Therapy of Ulcerative Colitis.- The Role of the Food and Drug Administration in Medical Therapy for Ulcerative Colitis
    The Natural History of Ulcerative Colitis
    Principles of Management of Ulcerative Colitis
    The Importance of Mucosal Healing in Ulcerative Colitis
    Oral Mesalamine
    Contrast and Comparison of Mesalamine Derivatives in the Treatment of Ulcerative Colitis
    Topical Mesalamine
    Oral and Parenteral Corticosteroid Therapy in Ulcerative Colitis
    Rectal Glucocorticoid Use In Ulcerative Colitis
    Antimetabolite Therapy in ulcerative colitis: Azathioprine, 6-Mercaptupurine and Methotrexate
    Azathioprine / 6-Mercaptopurine Metabolism in Ulcerative Colitis: A Guide to Metabolite Assessment: An Evidence Based Approach
    Cyclosporine for Ulcerative colitis
    Tacrolimus, Sirolimus and Mycophenolate Mofetil
    Infliximab for Ulcerative Colitis
    Beyond Infliximab: Other anti-TNF therapies for Ulcerative Colitis
    Novel Biologics for the Treatment of Ulcerative Colitis
    Probiotics, Prebiotics, and Antibiotics for Ulcerative colitis
    Novel NonBiologic Therapies for Ulcerative Colitis
    Disease Modifiers in the Management of Ulcerative Colitis
    Treatment of Ulcerative Proctitis
    Treatment of Distal / Left Sided Ulcerative Colitis
    Treatment of Severe Ulcerative Colitis
    Pregnancy and Fertility in Ulcerative Colitis
    Pediatric Issues in Treating Ulcerative Colitis
    Chemoprevention in Ulcerative Colitis
    Safety Considerations in the Medical Therapy of Ulcerative Colitis
    Management of Steroid-Dependent and Steroid-Refractory
    Medical Therapy of Ulcerative Colitis
    Medication Adherence in Ulcerative Colitis
    The Role of Telemedicine for Management of Ulcerative Colitis
    Assessment of Disease Activity in Ulcerative Colitis
    Medical Management of Toxic
    Medical Treatment of Extraintestinal Manifestation of Ulcerative Colitis
    Mimics of Ulcerative Colitis
    The role of diet and nutrition in ulcerative colitis
    Parenteral Nutrition Use in Ulcerative Colitis
    Maintenance of Remission in Ulcerative Colitis
    Management of Irritable Bowel Syndrome in the Patient with Ulcerative Colitis
    Medical Treatment of Hepatobiliary Diseases Associated with Ulcerative Colitis
    Step-Up versus Top-Down Therapy in Ulcerative Colitis.
    Digital Access Springer 2014
  • Article
    Belcher DW, Nicholas DD, Ofosu-Amaah S, Kratzer JH.
    Bull World Health Organ. 1979;57(2):301-7.
    Standard reporting systems have proved to be unreliable in estimating the frequency of paralytic poliomyelitis in many developing countries. The effectiveness of three survey methods for estimating the prevalence of lameness attributable to poliomyelitis were compared in the Danfa Health Project district of rural Ghana. Lameness was studied because it is easily identified by inexpensive survey techniques. A postal survey of school headteachers was the least costly and most accurate method, giving a prevalence of lameness attributable to poliomyelitis of 7.2 per 1000 schoolchildren. This method is recommended for countries with an extensive network of primary schools. Medical examinations in a village health survey yielded a prevalence of 4.6 per 1000 children aged 6-15 years. This method was relatively expensive but could be justified if the survey was multipurpose. A question added to the annual district census showed a prevalence of 2.2 per 1000 children, a rate still many times higher than estimates from national statistics. The inclusion of such a question in a census or other national survey entails little additional cost and with more careful questioning results should improve. Repeated surveys can be used to assess the success of poliomyelitis vaccination programmes.
    Digital Access Access Options